Shares of Immtech Pharmaceuticals Inc. plunged for the second time in two months after the company said it was discontinuing development of lead drug pafuramidine due to safety concerns. (BioWorld Today)
Shares of Immtech Pharmaceuticals Inc. plunged for the second time in two months after the company said it was discontinuing development of lead drug pafuramidine due to safety concerns. (BioWorld Today)
Strengthening its position as a major antibody player, Genmab A/S said it is securing its own manufacturing capability in a deal to acquire troubled PDL BioPharma Inc.'s Brooklyn, Minn., facility for $240 million. (BioWorld Today)
Strengthening its position as a major antibody player, Genmab A/S said it is securing its own manufacturing capability in a deal to acquire troubled PDL BioPharma Inc.'s Brooklyn, Minn., facility for $240 million. (BioWorld Today)
When it came to signing its first biotech collaboration since being founded in 2003, Acceleron Pharma Inc. made sure it was a big one. (BioWorld Today)
When it came to signing its first biotech collaboration since being founded in 2003, Acceleron Pharma Inc. made sure it was a big one. (BioWorld Today)
